NXT Post-Market Clinical Follow-up

Description

NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation to Confirm Ongoing Safety and Performance in Urodynamic Patient Sub-Populations

Conditions

Urinary Incontinence, Urinary Obstruction, Urinary Bladder, Overactive, Urinary Bladder, Neurogenic, Urinary Incontinence, Urge

Talk to us

Study Overview

On this page

Study Details

Study overview

NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation to Confirm Ongoing Safety and Performance in Urodynamic Patient Sub-Populations

NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation

NXT Post-Market Clinical Follow-up

Condition
Urinary Incontinence
Intervention / Treatment

-

Contacts and Locations

Hanover

Chesapeake Urology Hanover, Hanover, Maryland, United States, 21076

Owings Mills

Chesapeake Urology Owing Mills, Owings Mills, Maryland, United States, 21117

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients medically indicated for urodynamic study
  • * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • * Patients or legally authorized representative with cognitive or psychiatric condition that interferes with or precludes direct and accurate communication regarding the study, giving informed consent or ability to complete the patient questionnaire
  • * Patients with confirmed active bladder infections (not including patients with asymptotic bacteria)
  • * Pregnant women
  • * Patients with recent (less than 2 weeks) pelvic floor surgery
  • * Requires use of suprapubic catheter

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Laborie Medical Technologies Inc.,

Study Record Dates

2025-12